Complementary role of Ki67 index and 70-gene signature (MammaPrint) high-risk patients in the St Gallen risk group with uncertain chemotherapy suggestion.
Paolo Pronzato
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag
Giorgio Mustacchi
Honoraria - Agendia; Celgene; GlaxoSmithKline; Novartis; Pierre Fabre Medicament; Roche
Research Funding - Pierre Fabre Medicament
Daniele Giulio Generali
Research Funding - Pfizer; Roche
Alberto Bottini
Research Funding - Bayer; Roche